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DOI 10.1186/s13287-015-0082-5RESEARCH Open AccessThree-dimensional spheroid cell culture of
umbilical cord tissue-derived mesenchymal
stromal cells leads to enhanced paracrine
induction of wound healing
Jorge M Santos1†, Sérgio P Camões2†, Elysse Filipe2, Madalena Cipriano2, Rita N Barcia1, Mariana Filipe1,
Mariana Teixeira1, Sandra Simões2, Manuela Gaspar2, Diogo Mosqueira3,4, Diana S Nascimento3,4,
Perpétua Pinto-do-Ó3,4,5,6, Pedro Cruz1, Helder Cruz1, Matilde Castro2 and Joana P Miranda2*Abstract
Introduction: The secretion of trophic factors by mesenchymal stromal cells has gained increased interest given the
benefits it may bring to the treatment of a variety of traumatic injuries such as skin wounds. Herein, we report on a
three-dimensional culture-based method to improve the paracrine activity of a specific population of umbilical cord
tissue-derived mesenchymal stromal cells (UCX®) towards the application of conditioned medium for the treatment of
cutaneous wounds.
Methods: A UCX® three-dimensional culture model was developed and characterized with respect to spheroid
formation, cell phenotype and cell viability. The secretion by UCX® spheroids of extracellular matrix proteins and
trophic factors involved in the wound-healing process was analysed. The skin regenerative potential of UCX®
three-dimensional culture-derived conditioned medium (CM3D) was also assessed in vitro and in vivo against
UCX® two-dimensional culture-derived conditioned medium (CM2D) using scratch and tubulogenesis assays and
a rat wound splinting model, respectively.
Results: UCX® spheroids kept in our three-dimensional system remained viable and multipotent and secreted
considerable amounts of vascular endothelial growth factor A, which was undetected in two-dimensional cultures, and
higher amounts of matrix metalloproteinase-2, matrix metalloproteinase-9, hepatocyte growth factor, transforming
growth factor β1, granulocyte-colony stimulating factor, fibroblast growth factor 2 and interleukin-6, when compared
to CM2D. Furthermore, CM3D significantly enhanced elastin production and migration of keratinocytes and fibroblasts
in vitro. In turn, tubulogenesis assays revealed increased capillary maturation in the presence of CM3D, as seen by a
significant increase in capillary thickness and length when compared to CM2D, and increased branching points and
capillary number when compared to basal medium. Finally, CM3D-treated wounds presented signs of faster and
better resolution when compared to untreated and CM2D-treated wounds in vivo. Although CM2D proved to be
beneficial, CM3D-treated wounds revealed a completely regenerated tissue by day 14 after excisions, with a more
mature vascular system already showing glands and hair follicles.
Conclusions: This work unravels an important alternative to the use of cells in the final formulation of advanced
therapy medicinal products by providing a proof of concept that a reproducible system for the production of
UCX®-conditioned medium can be used to prime a secretome for eventual clinical applications.* Correspondence: jmiranda@ff.ulisboa.pt
†Equal contributors
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Most multipotent mesenchymal stromal cells (MSCs)
are capable of immune evasion and display immune-
suppressive properties, thereby providing an allogeneic,
ready-to-use, off-the-shelf cell product option for thera-
peutic applications [1,2]. Thus, the beneficial effect of
MSCs for the treatment of a variety of traumatic injuries
such as open wounds has been extensively explored
[3-6]. It was originally assumed that the observed bene-
fits were the result of cellular engraftment and differenti-
ation towards replacement of injured cells. However,
several reports demonstrate that it rather results from a
positive action on the tissue remodelling process via the
paracrine secretion of trophic factors, such as cytokines,
and/or cell-to-cell chemotactic interactions that modu-
late inflammation, immune reactions and activity of sur-
rounding cells [1,5,7-9]. Most of these data have been
obtained with bone marrow-derived MSCs (BM-MSCs)
[6,10], while increasing evidence shows that MSCs from
other sources could have distinct characteristics with
regards to differentiation, expansion potential with con-
comitant genomic stability, and tissue regeneration cap-
abilities [2,6,11].
Amongst the MSCs producing promising results in on-
going pre-clinical trials are the umbilical cord tissue-
derived MSCs, UCX® [12,13]. UCX® are isolated, expanded
and cryopreserved according to a patented method (PCT/
IB2008/054067; WO 2009044379) designed to produce a
highly homogeneous population of cells that comply with
the MSC standards as defined by the International Society
for Cellular Therapy [14]. Recently, the UCX® tissue re-
generation capacity has been functionally demonstrated in
several animal models for myocardial infarction and
rheumatoid arthritis [2,13]. Furthermore, our in vitro
studies, performed with conditioned medium (CM) pro-
duced by UCX® grown in classical two-dimensional mono-
layer cultures, have demonstrated the potential for
promoting cutaneous wound healing [12]. Namely, UCX®
were shown to be strongly motogenic towards keratino-
cytes and to be able to attract BM-MSCs in vivo, in a
one-way specific granulocyte-colony stimulating factor
(G-CSF)-mediated mechanism [12]. These results have
suggested positive UCX® implications in the early stages
of wound healing as well as in the proliferation and re-
modelling stages, through potential recruitment of cir-
culating CD34− CD45− cells that are known to promote
fibroblast migration, extracellular matrix (ECM) pro-
duction, angiogenesis and vasculogenesis [12]. More re-
cently and supporting our in vitro evidence, umbilical
cord Wharton’s jelly-derived MSCs (WJ-MSCs) have
been shown to consistently improve the healing re-
sponse in mouse models of dermal repair [15-17].
Routinely, MSCs are expanded and maintained in trad-
itional monolayer (two-dimensional) cultures where cellsmigrate and proliferate while adhering to the plastic sur-
face of static culture flasks. In addition, two-dimensional
systems consist of growth conditions that are further
away from the in vivo physiological environment, since
they lack three-dimensional cell-to-cell interactions. The
MSC phenotypes resulting from two-dimensional cul-
ture systems are therefore more limited in benefits that
a more matrix-like environment may bring. In an at-
tempt to recreate the complex microenvironment of liv-
ing systems, the use of MSC three-dimensional in vitro
culture models has gained increasing attention [1,18-22],
namely as a procedure for enhancing chondrogenic differ-
entiation [23] or for improving the therapeutic potential
of cells [1,19]. Recently, Sabapathy and colleagues [24]
found that WJ-MSCs seeded on decellularized amniotic
membrane scaffolds proved to have higher wound-healing
capabilities when transplanted onto skin injuries of SCID
mice model than WJ-MSCs alone, showing that a three-
dimensional environment can prime WJ-MSCs to a
more therapy-driven phenotype. Alternatively, a less
complex three-dimensional model is the spinner flask
suspension culture (SFSC), where cells self-assemble
into spheroid-like structures, thus enabling greater cell-
cell and cell-matrix interactions [19-22,25-27]. The
SFSC is also amenable for both cell expansion and dif-
ferentiation [28], as well as for up-scaling processes
avoiding some regulatory constraints related to adher-
ing supports and scaffolds. In this work, we aimed at
testing the hypothesis that the natural self-aggregation
of UCX® is an effective system for priming these cells
towards a paracrine activity that would further promote
wound healing. For this purpose, a reproducible and
scalable three-dimensional culture system using SFSC
for extended maintenance of multipotent UCX® spher-
oids was developed, devoid of supporting matrices or
the use of complex scaffolds. The environment within
UCX® spheroids successfully mimicked the native cell
microenvironment resulting in a richer secretome profile.
Indeed, our comparative analysis showed that the result-
ing three-dimensional conditioned medium (CM3D) im-
proved wound healing both in vitro and in vivo when
compared to two-dimensional conditioned medium
(CM2D). In summary, our three-dimensional culture
model may represent an alternative system to augment
the UCX®-driven potential to improve the regenerative
response of human skin to injury. The scalability of this
system further represents a new approach for the even-
tual production of UCX®-CM for therapeutic purposes,
avoiding the use of cells in the final medicinal product.
Materials and methods
Ethics and regulations
This study was approved by the Ethics Committee of the
Hospital Dr. José de Almeida (Cascais, Portugal), in the
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Development in Biotechnology, S.A.) and HPP Saúde
(Parcerias Cascais, S.A.). Umbilical cord donations, with
written informed consents, as well as umbilical cord
procurement, were made according to Directive 2004/
23/EC of the European Parliament and of the Council of
31 March 2004 on setting standards of quality and safety
for the donation, procurements, testing, processing,
preservation, storage and distribution of human tissues
and cells. All animal experiments were carried out with
the permission of the local animal ethical committee in
accordance with the EU Directive (2010/63/EU),
Portuguese law (DL 113/2013) and all relevant legisla-
tions. The experimental protocol was approved by
Direcção Geral de Alimentação e Veterinária.
Cell culture reagents
Cell culture media and supplements used in this work
were all purchased from Sigma-Aldrich (Madrid, Spain),
unless stated otherwise. Foetal bovine serum (FBS) and
Trypsin/ethylenediamine tetraacetic acid (EDTA) were
obtained from Gibco (Life Technologies, Madrid, Spain).
UCX® isolation and culture
UCX® were isolated from umbilical cords of healthy new-
born babies (57% male) upon informed consent of healthy
parturient mothers, according to Santos and colleagues
[2,29]. Briefly, fresh human umbilical cords were obtained
after full-term natural births, transported to the laboratory
facilities in a sterile container containing saline buffer and
processed within a period up to 48 hours. Identical cord
tissue sections were digested, using a precise ratio between
tissue mass, tissue digestion enzyme activity units, diges-
tion solution volume and void volume using collagenase.
The procedure includes three recovery phases in order to
avoid non-conformities related to percent cell recovery. In
the first cell recovery phase, cells dissociated from the tis-
sue are recovered by a static horizontal incubation. The
remaining cells are incubated in a static monolayer culture
in UCX® culture medium (α-modified Eagle’s medium
(MEM) with 2 mM L-glutamine, 1 g/L glucose, 2.2 g/L so-
dium bicarbonate) supplemented with 20% FBS, at 37°C
in 5% CO2 humidified atmosphere, with medium change
every 72 hours until they reached around 80% confluence.
Cells were cryopreserved in 10% dimethyl sulphoxide
(DMSO) stock solution and 20% FBS, using control rate
temperature decrease. When necessary UCX® cryopre-
served at passages between passage (P)3 and P5 were
thawed and further expanded during a maximum of 30
cumulative population doublings (cPDs), corresponding to
P12 in culture. The range of cPDs chosen allowed for
enough expansion for eventual production of large cell
numbers and amounts of CM but keeping cPDs within
the genomic stability range. UCX® are known to undergoat least 55 cPDs (P22) before reaching senescence and
keeping all MSC traits.
In two-dimensional (static monolayer) cultures, cells
were seeded at a density of 1 × 104 cells/cm2 in UCX®
medium supplemented with 10% FBS and incubated at
37°C in a humidified atmosphere with 5% CO2. Cell pas-
sage was performed by Trypsin/EDTA 0.05% incubation
for 5 minutes every 72 hours.
In three-dimensional (SFSC) cultures, 125 mL spinner
vessels with ball impeller containing UCX® medium sup-
plemented with 10% FBS were inoculated with single-
cell suspensions obtained from two-dimensional cultures
at a concentration of 1 × 106 cells/mL. To promote cell
aggregation, the spinner vessels were agitated at 80 rpm
and kept at 37°C in a humidified atmosphere of 5% CO2.
After 24 hours, 50% of cell culture supernatant was
changed with fresh UCX® medium supplemented with
10% FBS (v/v). Culture medium was replaced every 3 to
4 days to guarantee nutrient availability and to decrease
the accumulation of toxic by-products. The stirring rate
was adjusted to 110 rpm in order to keep spheroid size
below 350 μm.
For spheroid cell plating back into two-dimensional
cultures, a 5 mL cell suspension from three-dimensional
cultures was collected at day 7. Spheroids were digested
with 0.25% Trypsin/EDTA for 15 minutes resulting in
smaller spheroids that were inoculated in a six-well
plate. Cells were allowed to adhere in monolayer and
proliferate for 1 passage. Cells were then collected for
flow cytometry analysis of cell surface marker expres-
sion, and assessment of tri-lineage differentiation poten-
tial as described below.
UCX® characterization
Flow cytometry
Cell surface marker expression was analysed by flow cy-
tometry. For the characterization of UCX® in both two-
dimensional and three-dimensional cultures, both cell
detachment from culture flasks and dissociation from
spheroids were achieved by using 0.25% Trypsin/EDTA
and the resulting single cell suspension washed with 2%
bovine serum albumin (BSA) in phosphate-buffered sa-
line (PBS). Detection of cell surface markers was per-
formed with the following antibodies and their respective
isotypes after incubation for 1 hour at 4°C (all from BioLe-
gend (San Diego, CA, USA) unless stated otherwise):
phycoerythrin (PE) anti-human CD105 (eBioScience, San
Diego, CA, USA); APC anti-human CD73; PE anti-
human CD90; APC anti-human CD44; PerCP/Cy5.5
anti-human CD45; fluorescein isothiocyanate (FITC)
anti-human CD34; FITC anti-human CD31; PerCP/Cy5.5
anti-human CD14; Pacific Blue anti-human CD19 and
pacific-blue anti-human HLA-DR. All samples were
acquired on a Gallios (Beckman Coulter, Pasadena,
Santos et al. Stem Cell Research & Therapy  (2015) 6:90 Page 4 of 19CA, USA) and the results analysed with Kaluza software
(Beckman Coulter). A minimum of 1 × 104 events were ac-
quired per surface marker. One replicate was analysed per
independent experiment (n = 4).
Tri-lineage differentiation
Tri-lineage differentiation was performed in UCX® two-
dimensional and three-dimensional cultures. Spheroids
were dissociated into a single cell suspension with 0.25%
Trypsin/EDTA and transferred to the appropriate cul-
ture plates for cell proliferation and expansion. Adipo-
genic and osteogenic differentiation was performed
based on Lee and colleagues [30] and were initiated
when cultures reached 80 to 100% confluence. For the
chondrogenic differentiation [31], non-dissociated spher-
oids were also used for differentiation.
To induce adipogenic differentiation, UCX® were incu-
bated in UCX® medium supplemented with 20% FBS,
10 μg/mL insulin, 200 μM indomethacin, 0.5 mM isobu-
tylmetylxantine, and 1 μM dexamethasone for 3 days
and 1 day in UCX® medium supplemented with 20% FBS
and 10 μg/mL insulin. The medium was changed every
3 days for a period of 21 days. To induce osteogenic dif-
ferentiation, cells were incubated in UCX® medium sup-
plemented with 10% FBS, 10 mM β-glycerol phosphate,
100 nM dexamethasone and 50 μg/mL ascorbate-2-
phosphate. The medium was changed every 3 days dur-
ing 21 days. Finally, for chondrogenic differentiation,
cells (both dissociated cells and spheroids) were main-
tained in suspension as pellets, incubated with Dulbec-
co’s modified Eagle’s medium (DMEM) with 4 mM
glutamine and 1 g/L D-(+)-glucose, supplemented with
1% FBS, 6.25 μg/mL insulin, 10 ng/mL transforming
growth factor (TGF)-β1 (Tebu-bio, Le-Parray-en-
Yvelines, France), and 50 μM ascorbate-2-phosphate. The
medium was changed every 3 days during 21 days. Cyto-
chemical staining of cells was performed as described by
Wang and colleagues [32]. Briefly, cells were fixed with
paraformaldehyde 4% for 20 minutes. In adipogenic and
osteogenic differentiation protocols, cells were stained
with Oil Red O for 10 minutes and alkaline phosphatase
for 30 minutes, respectively. For chondrogenic differenti-
ation, the chondrospheres were fixed in formalin, embed-
ded in paraffin and cut into sections of 5 μm and stained
with alcian blue for 30 minutes. The presence of stained
cells was confirmed by inverted microscopy with phase
contrast (Leica, DMIL HC, Wetzlar, Germany).
UCX® viability evaluation
Protein quantification
Culture biomass within two-dimensional and three-
dimensional cultures was evaluated by quantification of
total protein using the BCA protein assay kit (Novagen,
San Diego, CA, USA), after lysis of the cell pellet with0.1 M NaOH at 37°C for 24 hours. A linear calibration
curve to relate total protein with cell number was gener-
ated to further estimate UCX® cell number.
Cell membrane integrity assay
The qualitative assessment of the cell plasma membrane
integrity during culture was performed using the enzyme
substrate fluorescein diacetate (Sigma-Aldrich) and the
DNA-dye propidium iodide (Sigma-Aldrich). Briefly, cell
aggregates were incubated with 20 μg/mL fluorescein
diacetate and 1 μg/mL propidium iodide in PBS for 2 to
5 minutes and then observed using an inverted fluores-
cence microscope (Nikon Eclipse Ti-U, Tokyo, Japan).
UCX® spheroid visualization and measurement
UCX® spheroids were observed by bright field microscopy
(Olympus CK30, Olympus, Tokyo, Japan), and their aver-
age diameter determined by a geometric mean of three di-
ameters per spheroid as described previously, using the
following equation: average diameter = (d1 × d2 × d3)1/3
[33]. Spheroid diameters were measured using Motic Im-
ages Version 2.0 software (Xiamen, China).
Haematoxylin and eosin staining
UCX® spheroids were resuspended in Tissue Tek® O.C.T.™
(Sakura, Zoeterwoede, The Netherlands) for preparing
cryosections of 10 μm. Slides were first stained with
Harris’s haematoxylin (Sigma-Aldrich) for 10 minutes,
followed by an incubation step with HCl 1% (v/v) in 70%
EtOH, and by Eosin Y (Sigma-Aldrich) staining for 2 mi-
nutes. Slides were then submitted to increasing concentra-
tions of ethanol and finally incubated in xylene (EMD
Chemicals, Inc., Gibbstown, NJ, USA). Samples were
mounted with Entellan® (Merck, Darmstadt, Germany).
Images were acquired on an Olympus CK30 inverted
microscope and processed using Motic Images Version
2.0 software.
Immunofluorescence microscopy
Cryosections from UCX® spheroids were prepared as de-
scribed above. Tissue sections were fixed with cold acet-
one for 10 minutes and blocked for 1 hour with 4% FBS
and 1% BSA in PBS. Incubation with primary antibody
was performed in a humified chamber for 2 hours at
room temperature or overnight at 4°C. The primary anti-
bodies used were: Ki67 (Rabbit IgG, AB16667, Abcam,
Cambridge, UK), diluted 1:100; Collagen IV (Goat, AB769,
Millipore, Billerica, MA, USA) diluted 1:10; Fibronectin
(Rabbit, F-3648, Sigma-Aldrich) diluted 1:400; Laminin
(Rabbit IgG, L9393, Sigma-Aldrich) diluted 1:50; collagen
I (Rabbit IgG, AB21285, Abcam) diluted 1:200. All pri-
mary antibodies were diluted in 1% BSA in PBS. The incu-
bation with secondary antibodies was carried out for
1 hour at room temperature. The secondary antibodies
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staining; rabbit anti-goat-biotin (1:400) followed by
streptavidin 555 (1:500) for Collagen IV staining; donkey
anti-rabbit IgG 568 (1:1000) for Laminin staining; donkey
anti-rabbit IgG 647 (1:1000) for Collagen I staining and
goat anti-rabbit 488 (1:1000) for Fibronectin staining.
All secondary antibodies were purchased from Invitro-
gen (Carlsbad, CA, USA). Sections were mounted using
ProLong gold antifade with DAPI (Invitrogen) or
Fluoroshield™ with DAPI (Sigma-Aldrich), and observed
on an inverted fluorescence microscope (Axiovert
200 M, Carl Zeiss, Oberkochen, Germany) coupled with
a monochrome camera (AxioCam MNC, Carl Zeiss).
Conditioned media preparation and evaluation
Conditioned media production
CM was produced from cells having undergone the same
number of cPDs.
UCX® CM3D was obtained by inoculation of cells as
described above, but subjected to successive medium
adaptation replacements in order to reduce FBS concen-
tration to 0%. At day 2 of culture, FBS concentration
was reduced to 5%. After 3 days, medium was changed
with UCX® medium without FBS and medium volume
adjusted accordingly, in order to obtain a conditioning
volume per cell as in the two-dimensional system. After
48 hours of conditioning, CM3D was collected under
sterile conditions.
For the production of UCX® CM2D, 1.75 × 106 cells
were seeded in 175 cm2 t-flasks and kept in UCX®
medium supplemented with 5% FBS until they reached
90% confluence. At this stage, cells were carefully washed
with fresh α-MEM and medium was replaced by α-MEM
without FBS, at a final volume of 25 mL. After condition-
ing for 48 hours, CM2D was harvested under sterile
conditions.
The control sample consisted of UCX® medium which
was never in contact with cells. CM3D, CM2D and con-
trol were concentrated 10× using 3-kDa cut-off spin
concentrators (Pall, Ann Arbor, MI, USA). Total protein
content of CM2D, CM3D and controls was quantified
using the BCA protein assay kit (Novagen) according to
the manufacturer’s instructions. Samples were stored at
−80°C until further use.
Methylthiazolyldiphenyl-tetrazolium bromide viability assay
The cytotoxicity of CM2D and CM3D was evaluated by
the methylthiazolyldiphenyl-tetrazolium bromide (MTT)
reduction assay on two cell types of cutaneous origin:
primary human dermal fibroblasts (HDF; ATCC cat:
PCS-201-012, Middlesex, UK), and the spontaneously
immortalized keratinocyte cell line (HaCaT; Cell-Line-
Service cat: 300493, Eppelheim, Germany). HDF and
HaCaT were seeded in 96-well plates at a density of1.5 × 104 cells/cm2 and 4.0 × 104 cells/cm2, respectively,
in DMEM with 4 g/L D-(+)-Glucose supplemented with
10% FBS in a humidified chamber at 37°C in a 5% CO2
atmosphere. After 24 hours of incubation, cell culture
medium was replaced by CM2D or CM3D 0.5×, 1×, 3×,
6× and 10× concentrated. Cells were also incubated with
200 μL complete cell culture medium and DMSO 20%
in α-MEM as a positive control and control of death, re-
spectively. After 48 hours, cells were carefully washed
with 100 μL PBS, and 200 μL 0.5 mg/mL MTT (Sigma-
Aldrich) in complete cell culture medium was added.
HDF were incubated for 3 hours and HaCaT for 45 mi-
nutes, both in a humidified chamber at 37°C in a 5%
CO2 atmosphere. The purple crystals were solubilized
with 200 μL DMSO and measured at 570 nm using a mi-
croplate spectrophotometer (SPECTROstar Omega; BMG
LabTech, Ortengerg, Germany). Results were expressed as
a percentage relative to the positive control. Four wells
were used for each sample, and three independent experi-
ments were performed.Elastin quantification
Elastin was quantified in HDF and HaCaT cells seeded in
12-well plates. At a confluence of 70 to 80%, cells were in-
cubated with UCX® medium containing: i) CM3D; ii)
CM2D; and iii) UCX® medium (control), 3× concentrated.
Elastin was quantified at 24 hours and 72 hours post-
incubation using the Fastin™ Elastin Assay Kit from Bioco-
lor (Carrickfergus, UK), according to the manufacturer’s
instructions. The Fastin Assay is a quantitative dye-
binding method for the analysis of elastins released into
tissue culture medium and extracted from biological ma-
terials, namely soluble tropoelastins, lathyrogenic elastins
and insoluble elastins (following solubilization to elastin
polypeptides α-elastin and κ-elastin). A total of two inde-
pendent experiments were performed.Gelatin zymography
CM derived from UCX® cultured in either two dimensions
(CM2D) or three dimensions (CM3D) and control (10 μg
total protein per lane) were separated in a 10% polyacryl-
amide gel containing 0.1% gelatin as substrate. Precision
Plus Protein™ Dual Color Standards (Bio-Rad, Hercules,
CA, USA), was used as protein standard. Following elec-
trophoresis, gels were washed twice in 2% Triton X-100
(Sigma-Aldrich) for 30 minutes. After rinsing in H2Odd,
gels were incubated in matrix metalloproteinase (MMP)
substrate buffer (50 mM Tris–HCl, pH 7.5; 10 mM CaCl2;
0.5% (w/v) NaN3) for 16 hours at 37°C. Gels were washed
once with H2Odd and stained with Coomassie Blue
(Sigma-Aldrich) solution for 30 minutes until bands be-
came clear. Band acquisition and density quantification
were performed using the Molecular Imager GS800
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on the protein amount measured in the cell supernatants.
Growth factor quantification
The concentrations of hepatocyte growth factor (HGF),
fibroblast growth factor (FGF)-2, vascular endothelial
growth factor (VEGF)-A, interleukin (IL)-6, TGF-β1,
keratinocyte growth factor (KGF) and C-GSF in the
CM2D, CM3D and control sample were evaluated by
means of a Fluorescent Bead Immunoassay kit (Flow-
Cytomix™, eBioscience) and an enzyme-linked immuno-
sorbent assay (ELISA) kit (Quantikine®, R&D Systems,
Minneapolis, MI, USA), for KGF quantification. Proto-
cols were performed as per manufacturer’s recommen-
dations. All samples were acquired on a Gallios
(Beckman Coulter) and the results were obtained using
FlowCytomix™ Pro 3.0 Software and expressed as pg/mL
of total protein, normalized in relation to the control. Re-
sults from three independent experiments are shown as
fold increase of CM3D relative to CM2D.
In vitro scratch assay
HDF and HaCaT cells were seeded into 24-well plates at a
seeding density of 1.5 × 104 cells/cm2 and 4.5 × 104 cells/
cm2, respectively, with DMEM with 4 g/L D-(+)-Glucose
supplemented with 10% FBS. Once at 80% (for HDF cells)
or 60 to 70% confluence (for HaCaT cells), cell media were
changed with DMEM with 4 g/L D-(+)-Glucose without
FBS for 24 hours. Scratches of ~0.5 mm in width were ex-
ecuted on the monolayer with a sterile pipette tip. Imme-
diately after, the cell surfaces were washed with PBS and
maintained in a final volume of 200 μL DMEM with 4 g/L
D-(+)-Glucose supplemented either with CM2D, CM3D
or control, all 3× concentrated. The area of the scratch,
from the same field, was measured at 0 and 40 hours
post-scratch as the result of an extensive optimization
period of the scratch assay with these two specific cell
types. The 40-hour time corresponds to the time period of
incubation immediately before the complete scratch
closure, and where cells were under the fastest migrat-
ing condition. Photographs were taken at an amplifica-
tion of 40× on a Motic AE2000 inverted microscope.
Cellular migration was analysed in the Motic Images
Version 2.0 program by calculation of scratch closure,
given as the total area occupied by the cells after con-
tact with CM, which was calculated in relation to the
initial scratch area at 0 hours. At least nine and six in-
dependent experiments in triplicates were performed in
HaCaT and HDF, respectively.
In vitro tubulogenesis assay
Early passage (P8-P10) human umbilical vein endothelial
cells (HUVECs; ScienceCell #8000, Carslbad, CA, USA),
were cultured in M199, 1% penicillin (100 mU/mL)/streptomycin (100 μg/mL) solution, supplemented with
10% FBS, 3 μL/mL ECGS (BD Biosciences) and 90 μg/mL
heparin. Cells were grown in flasks coated with 0.2% gel-
atin (Fluka, Buchs, Switzerland), until 70% confluence.
The tubulogenesis assay was performed as described in
Arnaoutova and colleagues [34] using the thick gel
method of preparation. In brief, Matrigel™ growth fac-
tor reduced (BD Biosciences) was thawed overnight and
poured carefully into eight-well chamberslide LabTeks
(Nunc, Wiesbaden, Germany), followed by incubation
at 37°C for 45 minutes in order to allow gelification.
HUVECs were then inoculated at a density of 4.5 × 104
cells/cm2 on top of the Matrigel™ in Endothelial Basal
Medium-2 (Lonza Basel, Switzerland), plus 1% penicil-
lin/streptomycin, supplemented (10× concentrated)
with basal medium (control) or CM2D or CM3D. Fol-
lowing incubation at 37°C and 5% CO2 for 3.5 hours,
cells were washed once in PBS and incubated with
3.2 μM Calcein AM (Sigma-Aldrich) for 30 minutes at
37°C. Finally, cells were washed, placed in Endothelial
Basal Medium-2 and visualized by fluorescent micros-
copy using an Axiovert 200 M inverted fluorescence
microscope (Carl Zeiss). Tube formation, number of
branching points, tube length and thickness were mea-
sured using ImageJ (US National Institutes of Health),
analysing approximately 25 fields per replicate (n = 3).
In vivo wound healing model
Male Wistar rats, 5- to 6-months old, were obtained
from Charles River Laboratories. All animals were accli-
matized before the experiments and housed in plastic
cages under standard laboratory conditions, fed com-
mercial chow and acidified drinking water ad libitum.
An excisional wound splinting assay consisting of an
adaptation of a protocol already described in mice that
was carried out on a rat model [35]. Briefly, after hair re-
moval from the dorsal surface, animals were anaesthetized
using intraperitoneal injection of ketamine (75 mg/kg;
Imalgene®, Merial, Lyon, France) and medetomidine
(0.5 mg/kg; Medetor®, Virbac, Burgdorf, Germany). Full-
thickness wounds were performed across the dorsum
midline using a sterile 8-mm punch biopsy tool (Kai
Medical, Gifu, Japan). To prevent skin contraction, a
donut-shaped splint was fashioned from a 0.5-mm thick
silicone sheet (Molecular Probes, Carlsbad, CA, USA).
Each animal carried four wounds to which 100 μL of
each sample 10× concentrated was applied via subcutane-
ous injection between the wound margin and the silicone
splint of the respective wound, as follows: 1) CM2D; 2)
CM3D; 3) control (UCX® medium that was never in con-
tact with cells); and 4) sham (natural wound resolution).
Sample administration was repeated after 24 hours, in a
total of three applications. Wounds were not covered by
any dressing but left to open air. Wound closure was
Santos et al. Stem Cell Research & Therapy  (2015) 6:90 Page 7 of 19defined as the time at which the wound bed was com-
pletely filled with new tissue and re-epithelialized. Wound
area was calculated as a percent area of the original
wound so that percentage of wound closure was defined
as follows: (area of original wound – area of actual
wound)/area of original wound × 100, being the wound
area measured by tracing the wound margin and calcu-
lated using an image analysis program (ImageJ). Figures
show representative images of three independent experi-
ments using five to six animals per time point.
Wound histological analysis
Animals were sacrificed at days 7, 9 and 14 for histological
analysis. The wound area was excised and fixed in 10%
neutral buffered formalin (Sigma-Aldrich) for haematoxy-
lin and eosin (H&E) staining. As part of the histological
evaluation, all slides were blindly examined by a patholo-
gist. A histological score was given to each slide according
to the parameters summarized in Table 1 (re-epithelializa-
tion, granulation tissue formation, vascularization and
wound margins distance).
Statistical analysis
Data analysis and graphs were plotted using GraphPad
Prism® software (GraphPad Software, San Diego, CA,
USA). Values presented in the text and figures are as
mean ± standard deviations of at least three independ-
ent experiments, except otherwise specified. To esti-
mate the significance of the differences of the growth
factor quantification and of the data obtained in the
in vivo assay, the parametric students t test was used.
The one way analysis of variance test using Tukey’s
post-hoc test for correction of multiple comparisons
was also performed. P < 0.05 was considered significant.
Results
UCX® form viable spheroids in spinner flask suspension
culture
A SFSC system was developed and optimized in order to
obtain UCX® three-dimensional spheroids (Figure 1). OnTable 1 Criteria for histologic scoring of wound healing
Score Re-epithelialization Wound margins distance
0 <25% of re-epithelialization Distant wound margins
1 25-50% of re-epithelialization Distant wound margins by
granulation tissue
2 50-75% of re-epithelialization Moderate distance between
wound margins
3 >75% of re-epithelialization Reduced distance between
wound margins
4 Complete re-epithelialization Closed wound marginsaverage, spheroid diameters were 143 ± 9.78 μm (value ±
standard error of the mean (SEM)) after 2 days and
309.5 ± 9.38 μm (value ± SEM) from day 4 to day 11 of
culture (Figure 1C). H&E staining revealed compact
spheroids with cells evenly distributed and embedded in
ECM presenting absence of an inner necrotic core up to
day 11, indicating that cells are viable within the core
of spheroids (Figure 1A). The surface of the spheroid
had a layer of epithelium-like cells that were flatter and
more elongated in appearance. Ki67 staining of spheroid
cryosections showed the presence of proliferating cells
within spheroids at days 3 and 11 (Figure 1B). However,
Ki67-positive cells comprised only a small fraction of cells,
indicating that only a low fraction (<5%) of cells were
actively proliferating in spheroids and this fraction of
proliferating cells decreases with time (Figure 1B). The
observed residual cell proliferation is in agreement with
the biomass values that did not significantly change
during culture time. The exception was between days 4
and 6 when the biomass value decreased due to
medium change that inevitably resulted in loss of still
non-aggregated cells (Figure 1D). From day 6 onwards,
where no single cells could be observed, no significant
differences were detected in biomass quantification and
no loss of biomass was detected after medium change
at day 9. The results showed that our optimized culture
conditions enabled the formation and maintenance of
UCX® spheroids comprising viable cells for at least
11 days and during the period of medium conditioning.UCX® grown in three-dimensional culture conditions
maintain mesenchymal stromal cell antigen expression
phenotype
UCX® cell-surface marker expression was analysed by flow
cytometry (see Additional file 1: Figure S1A). The surface
epitopes of UCX® dissociated from spheroids were similar
to the surface epitopes of UCX® obtained from adherent
monolayers (two-dimensional) dissociated under the same
conditions. From day 6 onwards, the population of three-
dimensional spheroid-dissociated cells showed a decreaseGranulation tissue Vascularization
Absent granulation Presence of haemorrhage
<30% of granulation tissue Presence of haemorrhage
and capillaries
Granulation in 30-60% of
wound bed
Presence of many
capillaries
>60% of granulation tissue Presence of few capillaries
Traces of granulation with
presence of mature collagen fibres
No evident vascularization
Figure 1 Spinner flask suspension cultures allow for the extended maintenance of UCX® spheroids without necrotic centres. (A) Phase contrast and
fluorescence representative images of spheroids at days 3, 9 and 11. (Top) Haematoxylin and eosin (H&E) staining of UCX® spheroid sections. Scale
bar = 100 μm; n = 3. (Bottom) Viability of UCX® spheroids in culture as assessed by staining with fluoresceine diacetate (FDA; live cells, green) and
propidium iodide (PI; dead cells, red). Scale bar = 100 μm; n = 3. (B) Representative immunofluorescence images of UCX® spheroid cryosections labelled
with Ki-67 (red) at days 3 and 11 in culture. Nuclei were labelled with DAPI (blue). Scale bar = 100 μm; n = 3. (C) Sizes of UCX® spheroids at days 2, 4, 6, 7, 9
and 11. Sizes were measured from 7 to 13 captured images of spheroids. Spheroids reached an average size of 308 ± 9.84 μm from day 4 onwards. Data
are shown as mean ± standard error of the mean; n = 3. (D) Biomass quantification measured by BCA kit at days 2, 4, 6, 8, 9 and 11. Data are shown as
mean ± standard deviation; n = 3. **P< 0.01; ***P< 0.001.
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etry side scatter results indicate that cells grown in three-
dimensional spheroids were approximately 30% smaller in
size when compared to cells grown in two-dimensional
monolayer cultures (results not shown). The expression ofCD105 and CD90 surface epitopes increased again to high
levels once UCX® grown in three-dimensional spheroids
were plated back (from culture day 7) in monolayer
conditions (spheroids plated back in two-dimensions;
see Additional file 1: Figure S1A).
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stromal cell differentiation potential after being plated
back in two-dimensional culture conditions
In order to assess if three-dimensional culture condi-
tions altered hallmark properties of UCX®, namely their
differentiation potential, cells in three-dimensional cul-
ture were dissociated from spheroids at days 3, 6 and 9,
plated onto culture flasks and grown as monolayers.
Plated cells retained the ability to adhere and proliferateFigure 2 Expression of extracellular matrix proteins by UCX® spheroids. Im
three-dimensional culture demonstrate the expression of relevant extracellula
define the basal lamina surrounding UCX® which is in close association with t
was observed irrespectively of the culture duration when considering the anaon a plastic surface. Cell multipotency was then assessed
and confirmed by the ability of UCX® to differentiate
in vitro into adipocyte-, osteoblast- and chondrocyte-like
cells (see Additional file 1: Figure S1B). Adipogenic and
osteogenic biochemical differentiation, evidenced by
lipid vacuole formation and matrix mineralization, re-
spectively, could be confirmed at all time points. In turn,
chondrogenic differentiation was attempted using both
three-dimensional spheroid-dissociated cells and intactmunostaining of representative cryosections of UCX® grown in
r matrix (ECM) molecules. Within the spheroid, laminin and collagen IV
he ECM proteins fibronectin and collagen I. A similar ECM composition
lysed time-points of day 3, 9 and 11. Scale bar - 100 μm; n = 3.
Santos et al. Stem Cell Research & Therapy  (2015) 6:90 Page 10 of 19three-dimensional spheroids directly. As expected, chon-
drocyte differentiation was obtained with dissociated
cells, but was greatly enhanced by cells in aggregates
already embedded in their own chondrogenic-type ECM.
Overall, cells obtained from three-dimensional cultures
and plated back under two-dimensional conditions show
a similar differentiation capacity as cells grown in con-
ventional two-dimensional cultures at similar passages.
UCX® spheroid structures mimic the native environment
ex vivo
To evaluate whether the UCX® spheroids replicate the na-
tive tissue environment ex vivo by producing the Whar-
ton’s jelly ECM, the expression of major ECM proteinsFigure 3 The production and secretion of matrix metalloproteinases (MMPs)
conditioned medium produced by UCX® cells in two-dimensional (CM2D; lan
(A) Zymogram analysis demonstrates that different culture conditions result i
high molecular weight (~130 kDa) set of bands depicting MMP complexes, an
pro-MMP-2 (~72 kDa), MMP-2 (~66 kDa) and an additional low molecular wei
proteolytic activity in gelatin substrates (possibly MMP-1 or −13). (B) Quantific
experiments (n = 3) indicates that UCX® seeded under three-dimensional con
zymogen and the active isoform. ***P < 0.001.and the activity of MMP was analysed. Immunohisto-
chemical evaluation of cells in spheroids showed sustained
expression of the ECM components collagen I and fibro-
nectin, as well as of the basement membrane proteins
laminin and collagen IV, between days 3 and 11 in vitro
(Figure 2). Moreover, no differences in terms of ECM dis-
tribution/composition between the aggregate inner core
and outer layer in any of the different-sized aggregates
were observed. A uniform distribution of laminin, collagen
IV and fibronectin expression, with interspersed regions of
collagen I deposition, generically characterized the UCX®
spheroids.
Gelatin zymography analysis demonstrated that UCX®
spheroids secreted the latent zymogen as well as thewas increased in UCX® cells within spheroids. Gelatin zymography of
es 1 and 2) or three-dimensional (CM3D; lanes 3 and 4) culture conditions.
n variations of the content of produced MMPs. All the samples display a
d also single MMPs such as pro-MMP-9 (~92 kDa), MMP-9 (~82 kDa),
ght (~45 kDa) set of bands that could refer to other MMPs with residual
ation of proteolytic bands by densitometric analysis of three independent
ditions produce higher relative amounts of MMP-9 and MMP-2, both the
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respectively) and MMP-9 (92 kDa and 82 kDa, respect-
ively) (Figure 3A). When compared to the CM obtained
from adherent cultures (CM2D), higher activity of MMP-
2 and MMP-9 forms was detected on CM3D (1.41-fold
and 1.79-fold, respectively). Moreover, densitometry ana-
lysis of the proteolytic bands further confirmed significant
differences in the amount of the zymogen and active
MMP-2 and MMP-9 isoforms between the two CM in
three independent experiments (Figure 3B). The presence
of other gelatinolytic MMPs was detected in CM3D, and
in very low amounts in the CM2D, with a molecular
weight of ~45 kDa which is compatible with either MMP-
1 activity or MMP-13 residual gelatinase activity
(Figure 3A).UCX® spheroids present a secretome richer in trophic
factors involved in wound healing
In order to evaluate whether our three-dimensional cul-
ture conditions direct UCX® to secrete a trophic factor
profile richer in wound healing-related factors, when com-
pared to two-dimensional cultures, a comparative analysis
of seven representative trophic factors with vital import-
ance in the consecutive stages of wound healing was per-
formed. VEGF-A, TGF-β1, KGF, FGF-2, IL-6, G-CSF and
HGF were quantified from CM3D and CM2D produced
in similar conditions in terms of relative amount of cells,
having undergone an equivalent number of cPDs, condi-
tioning volume and conditioning time, and eliminatingFigure 4 The secretion of growth factors involved in the wound-healing pro
transforming growth factor (TGF)-β1, granulocyte-colony stimulating factor (G
factor (FGF)-2 and interleukin (IL)-6 were quantified in two-dimensional condi
(CM3D) using a FlowCytomix™ kit. Keratinocyte growth factor (KGF) was quan
Results are expressed as fold-increase of CM3D relative to CM2D. Data are shoserum contribution. UCX® grown and maintained either
in spheroids or monolayers resulted in different secretome
profiles. In particular, the levels of HGF, TGF-β1, IL-6 and
G-CSF found in CM3D were higher than in CM2D
(Figure 4). Finally, a 15-fold increase in FGF-2 levels was
observed in CM3D when compared to CM2D. Most im-
pressively, VEGF-A, which was only residually expressed
in the two-dimensional system, was highly expressed by
UCX® under three-dimensional conditions (80-fold higher
than CM2D). In turn, KGF expression was found to be
significantly higher in CM2D versus CM3D. Overall,
the results strongly suggested an improved paracrine
effect of CM3D onto fibroblast-mediated ECM synthe-
sis, angiogenesis and vasculogenesis, essential for the
granulation tissue formation and remodelling stages of
wound healing [36].The UCX® paracrine induction of skin cell migration,
proliferation and tubulogenesis in vitro is enhanced when
cells are cultured as spheroids
The functional effects of CM produced by UCX® cultured
as spheroids were investigated regarding three essential
aspects of skin regeneration; that is, skin cell migration,
proliferation and angiogenesis. The capacities for cellular
migration and proliferation of keratinocytes (by means of
the HaCaT cell line) and dermal fibroblasts (HDF) were
quantified using in vitro scratch and cell viability assays,
respectively. Moreover, the sprouting of new capillaries
was assessed by the formation of capillary-like structurescess was increased in UCX® spheroids. Hepatocyte growth factor (HGF),
-CSF), vascular endothelial growth factor (VEGF)-A, fibroblast growth
tioned medium (CM2D) and three-dimensional conditioned medium
tified in CM2D and CM3D by enzyme-linked immunosorbent assay.
wn in mean ± standard deviation; n = 3.
Figure 5 (See legend on next page.)
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Figure 5 UCX® spheroid-derived conditioned medium (CM3D) enhances immortalized keratinocyte cell line (HaCaT) and human dermal fibroblasts
(HDF) cell migration, proliferation and elastin production. (A) Graphs represent the average area occupied by the HaCaT cells after 40 hours in contact
with serum-free conditioned medium from three-dimensional cultures (CM3D), two-dimensional cultures (CM2D) and control (basal medium). Data are
shown as mean ± standard deviation (SD); n = 9 to 12. (B) Representative images of HaCaT scratch-wound assays immediately after the scratches had
been made (0 h) and then after 40 hours in the presence of serum-free CM3D, CM2D and control. (C) Graphs represent the average area occupied by
the HDF after 40 hours with CM3D, CM2D and control. Data are shown as mean ± SD; n = 6 to 9. (D) Representative images of HDF scratch-wound
assays immediately after the scratches had been made (0 h) and then after 40 hours in the presence of serum-free CM3D, CM2D and control. (E) HaCaT
and HDF viability evaluated by methylthiazolyldiphenyl-tetrazolium bromide (MTT) reduction assay after 48 hours of incubation with CM2D and CM3D. Data
are shown as percentage of control (Crtl) and as mean± standard error of the mean; n = 3. (F) Elastin production by HaCaT and HDF at 24 and 72 hours
post-incubation with CM3D, CM2D and control. Data are shown as mean ± SD; n = 2. *P< 0.05; **P< 0.01; *** P< 0.001. CM, conditioned medium.
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assays. The keratinocyte migration into the scratch wound
area was accelerated in the presence of CM3D when com-
pared to CM2D (Figure 5A). Using digital image analysis,
we have quantified the scratch areas that have been closed
resulting in a statistically significant (P < 0.001) increase in
HaCaT migration, in the presence of CM3D, of approxi-
mately two- and four-fold when compared to CM2D and
control samples, respectively (Figure 5A,B). In addition,
CM3D significantly induced HaCaT proliferation (at all
concentrations except 10×, P < 0.01) while CM2D resulted
only in a slight mitogenic effect (P < 0.05 for 0.5× concen-
tration; Figure 5E). With regards to the migration of HDF,
although not statistically significant, CM3D also provided
a noticeable increase in cell migration when compared to
CM2D (Figure 5C,D). In turn, according to our cell viabil-
ity assays, HDF viability was enhanced by CM3D up to
40% compared to the control, whereas CM2D revealed no
considerable effect on HDF viability, especially at higher
concentrations (6× and 10×; Figure 5E). Furthermore,
consistent with our scratch assay results, CM3D was
found to enhance the production of elastin in both HaCaT
and HDF (Figure 5F), a protein known to be involved in
multiple functions during wound healing by virtue of its
mechanical and signalling properties. After 72 hours in
culture, the increase in elastin concentration was statisti-
cally significant in HaCaT cells both with respect to elastin
concentration at 24 hours in culture and with respect to
the control at 72 hours. We have further addressed
whether CM3D would induce the in vitro formation of
capillary-like structures by endothelial cells (HUVECs).
Tubule formation by HUVECs consistently showed a
significant increase in capillary number, thickness and
length, and number of branching points in the presence
of CM3D when compared with control (P < 0.001;
Figure 6A,B). Interestingly, while CM3D-supplemented
medium still resulted in significantly thicker and longer
capillary structures when compared to CM2D, the
latter slightly induced the formation of more capillaries
and branching points (Figure 6A,B). Overall, these re-
sults demonstrate for the first time that UCX® favour
maturation of neo-formed capillaries via a paracrinemechanism, and that this activity is further increased
by culturing UCX® as spheroids in our optimized three-
dimensional setting.
Three-dimensional conditioned medium enhances the
wound-healing capacity in vivo in a rat excisional wound
splinting model
To examine whether CM could enhance wound healing
in vivo consistent with the potential therapeutic effects ob-
served in vitro, an excisional wound splinting assay was
carried out using Wistar rats as an animal model. Macro-
scopic observations showed that CM-treated wounds
clearly exhibited accelerated wound closure when com-
pared to both types of control wounds. Full closure in
wounds treated with CM3D and CM2D was significantly
faster than the control, having been reached at days 12
and 13, respectively (Figure 7A). Additionally, a thorough
histological analysis resulted in the observation of signifi-
cant differences between CM-treated and CM-untreated
wounds, especially with regards to granulation tissue for-
mation from day 9 onwards (Figure 7B,C). Furthermore,
at day 9, CM2D- and CM3D-treated wounds already pre-
sented signs of faster wound resolution, given the higher
scores observed for wound margin distance (P < 0.05 for
CM3D), complete re-epithelialization (P < 0.05 and P <
0.01, respectively) and higher vascularization level (P <
0.01 for both CM2D and CM3D), when compared to the
natural resolution (sham) control. Indeed, both controls
could only achieve a highest histological score for the re-
epithelialization parameter and only at day 14 (Figure 7C).
In turn, the evaluation of other parameters related to new
tissue formation have revealed slightly different healing
stages between CM3D- and CM2D-treated wounds. In
general, CM3D-treated wounds at day 14 presented a tis-
sue which appeared completely regenerated, with a more
mature vascular system, based on the presence of several
organized capillaries, and already showing cell appendages
such as glands and hair follicles (Figure 7B). Meanwhile,
CM2D-treated wounds still presented on-forming granu-
lation tissue with some mature collagen fibres being ob-
served and both controls still on the verge of full closure
(Figure 7B). Overall, the results demonstrate that CM
Figure 6 UCX® spheroid-derived conditioned medium (CM3D) enhances capillary formation in vitro. (A) Representative images of Calcein AM marked
human umbilical vein endothelial cells on Matrigel, in contact with control (basal media), CM2D and CM3D. (B) Graphs represent a quantitative analysis
of capillary thickness, length, branching point number and capillary number. Data are shown as mean ± standard deviation; n = 3. *P < 0.05; **P < 0.01;
***P < 0.001. CM2D, two-dimensional conditioned medium; CM3D, three-dimensional conditioned medium.
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promotes an acceleration and improvement of the
wound-healing process.
Discussion
Increasing evidence supports that MSCs have a role in tis-
sue repair and regeneration, not so much by means of cel-
lular differentiation but rather via the secretion of soluble
trophic factors that enhance the response of damaged tis-
sues through paracrine activation of surrounding cells
[8,37,38]. Most of the MSC application studies performed
so far have been performed using MSCs cultured in static
monolayer cultures. However, several publications suggest
that a three-dimensional environment may be more
physiologically relevant than traditional two-dimensional
systems mainly by increasing cell-to-cell interactions. In-
deed, previous work has shown that WJ-MSCs have
higher wound-healing capabilities when seeded on mem-
brane scaffolds prior to transplantation onto skin injuries
in vivo, demonstrating that a three-dimensional environ-
ment can prime WJ-MSCs to a more therapy-driven
phenotype [24,39]. However, the use of scaffolds or other
attachment materials often adds on regulatory hurdles to
the already intrinsically complex process of approving ad-
vanced therapy medicinal products. Alternatively, MSCs
have been cultured and maintained in self-assembled
spheroids. Such cellular structures have demonstratedimproved therapeutic potential by increasing the expres-
sion of C-X-C chemokine receptor type 4, IL-24 or
tumour necrosis factor-inducible gene 6 protein and pros-
taglandin E2 genes that promote adhesion to endothelial
cells, and have tumour suppressing or anti-inflammatory
properties, respectively [1,19,40,41]. Along this line of
thought, the work presented here aimed at: i) establishing
a consistent protocol for obtaining UCX® spheroids with
an improved “healing” secretome compared to that ob-
tained from UCX® expanded and maintained in traditional
monolayer cultures; and ii) to use the medium condi-
tioned by such UCX® spheroids as the therapeutic agent
for the treatment of open skin wounds.
UCX® spheroids were successfully cultured and main-
tained in suspension using a spinner flask with a ball im-
peller. The formation of necrotic centres that may occur
in aggregates larger than 350 μm was a concern [42].
This was circumvented by controlling the stirring rate,
as shown in the H&E analysis. In fact, under our opti-
mized conditions, spheroids maintained high cell viabil-
ity for up to at least 11 days, whereas cell proliferation
was stalled (<5%) when compared to monolayer cultures.
Additionally, the MSC character of the UCX® in spher-
oids promoted stemness maintenance as per the recom-
mendations of the International Society for Cellular
Therapy [14]. A decrease in CD105 and CD90 expres-
sion levels was the exception, most likely due to the
Figure 7 (See legend on next page.)
Santos et al. Stem Cell Research & Therapy  (2015) 6:90 Page 15 of 19
(See figure on previous page.)
Figure 7 UCX® three-dimensional culture-derived conditioned medium (CM3D) enhanced wound healing in vivo. (A) Graph represents the day of
closure of wounds treated with two-dimensional conditioned medium (CM2D), CM3D and control. Data are shown as mean ± standard error of
the mean (SEM); n = 6. (B) Representative images (left) of macroscopic view and (right) histological slices stained by haematoxylin and eosin of
CM2D-treated, CM3D-treated, control and sham-treated wounds at day 14; n = 6. (C) Graphs represent the histological scores (top to bottom) of
wound margin distance, re-epithelialization, granulation tissue and vascularization, evaluated in CM2D-, CM3D-, control and sham-treated wounds
at days 7 (n = 4), 9 (n = 5) and 14 (n = 6). Data are shown as mean ± SEM. *P < 0.05; **P < 0.01. GT, granulation tissue; Ep, epithelium; HF, hair
follicle; Gl, gland.
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a lower yield of fluorescence emission, shifted the signal
to the negative region of the histograms - an observation
previously reported by Bartosh and colleagues [1]. The
dynamics of cell aggregation are mediated by cell adhe-
sion molecules, where single cells firstly aggregate
through integrin binding into loose aggregate spheroids.
Afterwards, it has been shown that E-cadherin interac-
tions are the major factor for the cell morphological
transition from loose cell aggregates to compact spher-
oids. Therefore, cells within spheroids may be smaller in
size than cells grown in monolayer cultures [43,44].
Moreover, evidence indicates that a crucial component
of the stem/progenitor cell niche is the ECM which mod-
ulates cell fate by making available a large array of bio-
chemical and biophysical cues. Wharton’s jelly is a
connective tissue layer very rich in ECM fibrous proteins,
interstitial proteins and signalling molecules, whereas the
WJ-ECM is mainly composed of collagens such as colla-
gen type I, II, III, IV and VI, laminin and fibronectin [45].
Immunostaining of UCX® spheroids showed that cells
were embedded in a rich ECM composed of mainly colla-
gen I, fibronectin, laminin and collagen IV, suggesting that
an environment resembling that of the native tissue was
formed within the aggregates. Besides, it has been demon-
strated that the preservation of an endogenous ECM in
human MSC aggregates improves multi-lineage potential
and survival under ischaemic stress [45]. Thus, the pro-
duction of ECM within the aggregate may have also in-
creased the overall cell homeostasis, preserving cells from
entering apoptosis.
Previous studies using mRNA/cDNA microarrays
demonstrated marked differences between transcriptome
profiles of MSCs maintained in spheroids versus MSCs
cultured in monolayers, including those confirming
widespread changes to the cellular architecture and
ECM [19,40,46]. The fact that the cell proliferation/me-
tabolism is rather different between the two systems
may also have an important effect upon the overall cellu-
lar activity leading to large differences in the secretion of
relevant paracrine factors. Herein, a representative group
of growth factors was selected, involved in important
mechanisms of tissue regeneration, including all wound-
healing phases from tissue haemostasis to remodelling.
The corresponding analysis was performed in samplesconcentrated 10× using a 3-kDa cut-off; that is, lower
than the molecular weight of the selected factors. Ac-
cording to our quantification analysis, VEGF-A, FGF-2,
HGF, TGF-β1, G-CSF and IL-6 are consistently secreted
in higher amounts by UCX® maintained in spheroids,
when compared to UCX® grown in static monolayer cul-
tures. In turn, and according to our previous results
where CM2D was found to have a prominent motogenic
effect on keratinocytes and therefore on the early epithe-
lization stage of wound healing [12], KGF expression
was significantly higher in CM2D when compared to
CM3D. Of special note was the high production by
UCX® spheroids of VEGF-A and FGF-2, both conspicuous
growth factors involved in neo-vascularization and regula-
tion of tissue homeostasis, respectively [47]. Expression of
both VEGF-A and FGF-2 was only residually detected in
UCX® grown and maintained in two-dimensions in our
experimental conditions. This is consistent with previous
findings by Potapova and colleagues [46] using hanging
drop human MSCs three-dimensional aggregates [46]. In
turn, HGF and TGF-β1 have also been highly induced by
our three-dimensional culture conditions. Both factors
have been implicated in keratinocyte cell migration across
the fibronectin-rich provisional wound matrix during the
healing process by promoting MMP, ECM protein, integ-
rin and collagenase secretion [48-53]. TGF-β1 has also di-
verse stimulatory roles in cutaneous wound healing,
namely in re-epithelialization, wound contracture, vascu-
logenesis, scar formation and ECM deposition [7]. Many
of these processes involve the regulation of elastin expres-
sion which plays a vital role in tissue structure and func-
tion by inducing a range of cell activities, including cell
migration and proliferation, matrix synthesis, and protease
production. When elastin is inadequately expressed due to
wound healing, an intact elastic fibre network is absent
contributing to poor remodelling and therefore dimin-
ished physical properties when compared with uninjured
skin. After injury, the restoration of an intact and func-
tional elastic fibre network is therefore critical to regain
complete skin function [54]. Herein, CM3D induced elas-
tin production by HaCaT and HDF over time, suggesting a
UCX®-CM contribution to the synthesis of a functional
elastin fibre network. Furthermore, improvement in
MMP-9 activity, together with augmented HGF secretion,
stimulated by our three-dimensional culture conditions,
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cyte/fibroblast migration observed in our in vitro migra-
tion and proliferation assays. MMP-9 has been implicated
in enhanced invasive potential of keratinocytes in response
to EGF and HGF [55]. The secretion of both MMP-2 and
MMP-9 has been associated with MSC recruitment and
infiltration into injured tissues in vivo [56]. Thus, the
higher production of both MMP-9 and MMP-2 by UCX®
spheroids may reflect the requirement to surmount the
complex ECM mesh formed within the spheroid when
compared to the plane basement membrane formed in
monolayers.
Correct cutaneous wound repair requires a well-
coordinated response of platelet recruitment, inflam-
mation (infiltrate-cell mobilization), cell migration and
granulation tissue formation, neovascularization, ECM
degradation/formation, and epithelialization. Failure of
any of these processes due to ischaemia, reperfusion in-
jury, bacterial infection, or ageing can result in chronic
inflammation and/or a non-healing wound [6,57]. Pre-
viously we have observed an important role of CM2D
produced by UCX® in the early epithelialization stages
of cutaneous wound healing due to the expression of
G-CSF, endothelial growth factor, FGF-2 and KGF, and
their impact in the induction of keratinocyte activity
[12]. The role of CM2D produced by UCX® on the later
proliferation and remodelling stages of wound healing
seemed to be more indirect, by recruiting other local
and circulating MSCs (such as BM-MSCs) via a G-CSF-
mediated mechanism [12]. Herein, the CM3D-mediated
induction of VEGF-A and FGF-2, together with increased
expression of HGF and TGF-β1, strongly supports a
CM3D-specific enhancement of fibroblast proliferation
and function, with concomitant enhancement of the
granulation process. Also, the high expression levels of
VEGF-A obtained in CM3D (non-detected in CM2D in
our experimental conditions) indeed suggested an in-
creased potential to induce angiogenesis and vasculogen-
esis in vivo, corroborated by our in vitro tubulogenesis
results [58]. Additionally, G-CSF, with important implica-
tions in platelet and infiltrate cell recruitment, keratino-
cyte migration and function as well as mobilization of
resident and circulating haematopoietic and MSCs [7],
could also be detected at higher levels in CM3D. In fact,
both CM3D- and CM2D-treated wounds in vivo pre-
sented accelerated closure (around 17% and 14%, respect-
ively) showing complete re-epithelialization and higher
vascularization levels when compared to the controls.
However, unlike CM2D-treated wounds, CM3D-treated
post-closure wounds, 14 days after excisional infliction,
presented a completely regenerated tissue, with a mature
vascular system with organized capillaries, but already
showing glands and hair follicles. Taken together, the
CM3D biochemical composition seems to have promotedthe later proliferative and remodelling stages of wound
healing, when compared to CM2D, which can explain the
advanced tissue regeneration profile observed in vivo.Conclusions
A reproducible and scalable SFSC system for the mainten-
ance of viable, multipotent UCX® within self-assembled
spheroids was developed. The microenvironment estab-
lished within the spheroids acted in an autocrine fashion
favouring an enhanced secretion of healing-inducing para-
crine factors by UCX®, including the ECM proteins, colla-
gen I, fibronectin, laminin and collagen IV; MMP-2,
MMP-9, VEGF-A, G-CSF, HGF, FGF-2, TGF-β1 and IL-6.
The resulting conditioned medium (CM3D) has the po-
tential to increase elastin production, skin cell mobility
and further induce tubulogenesis in vitro. The enhanced
CM3D healing potential in vitro was corroborated in vivo
in an excisional wound splinting model, resulting in a fas-
ter wound closure and regeneration into a more mature
fully functional tissue. Finally, by resorting to a repro-
ducible and scalable three-dimensional culture system,
this work presents an important advantage with regards
to an eventual CM production for clinical and indus-
trial applications.Additional file
Additional file 1: Figure S1. Figure presenting the data regarding the
surface protein expression and tri-lineage differentiation of UCX® spheroids,
as described in the corresponding figure legend: UCX® spheroids retain the
properties of MSCs from adherent cultures. (A) Flow cytometry of
surface protein expression on UCX® spheroids at days 3 (D3), 6 (D6), 9
(D9) and 11 (D11) in culture; on UCX® cells collected from spheroids
from three-dimensional cultures at day 7 and plated back into two-
dimensional cultures; and on UCX® originally cultured in two-dimensional
conditions. Cells were dissociated from spheroids with Trypsin/EDTA prior to
flow cytometry analysis; n = 4. (B) Representative images of the
differentiation of UCX® spheroids (three-dimensional) into osteoblast-like
cells, chondrocyte-like cells, adipocyte-like cells and respective controls
(two-dimensional). Cultures were stained with alkaline phosphatase, alcian
blue and oil red O, respectively. Scale bar = 100 and 400 μm.Abbreviations
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conditioned medium; CM3D: three-dimensional conditioned medium;
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medium; DMSO: dimethyl sulphoxide; ECM: extracellular matrix;
EDTA: ethylenediamine tetraacetic acid; FBS: foetal bovine serum;
FGF: fibroblast growth factor; FITC: fluorescein isothiocyanate; G-
CSF: granulocyte-colony stimulating factor; H&E: haematoxylin and eosin;
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